StockClub

PHGUF

PHGUFPharming Group N.V.$ --
Pharming Group N.V.

Pharming Group N.V.

PHGUF

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
91M EUR
YoY -1.3%
Operating Income
2M EUR
YoY -74.4%
Net Income
5M EUR
YoY +26.8%
EPS
0.01EUR
YoY +38.0%

Revenue

EUR361.1M
FY2024 Q1EUR55.3M
EUR55.3M
Q1
FY2024 Q2EUR129M
EUR129M
Q2
FY2024 Q3EUR203.8M
EUR203.8M
Q3
FY2024 Q4EUR296.5M
EUR296.5M
Q4
FY2025 Q1EUR79.1M
EUR79.1M
Q1
FY2025 Q2EUR172.3M
EUR172.3M
Q2
FY2025 Q3EUR269.6M
EUR269.6M
Q3
FY2025 Q4EUR361.1M
EUR361.1M
Q4
Actual
+EUR64.6M (+21.8%)

Net Income

EUR2.1M
FY2024 Q1EUR-12.4M
EUR-12.4M
Q1
FY2024 Q2EUR-13.6M
EUR-13.6M
Q2
FY2024 Q3EUR-14.6M
EUR-14.6M
Q3
FY2024 Q4EUR-11M
EUR-11M
Q4
FY2025 Q1EUR-14.7M
EUR-14.7M
Q1
FY2025 Q2EUR-10M
EUR-10M
Q2
FY2025 Q3EUR-2.5M
EUR-2.5M
Q3
FY2025 Q4EUR2.1M
EUR2.1M
Q4
Actual
+EUR13.1M (+118.8%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:EUR228.4M
Est:EUR270.9M
FY2020MISS
EUR228.4M
FY2021MISS
Actual:EUR189.9M
Est:EUR253.5M
FY2021MISS
EUR189.9M
FY2022MISS
Actual:EUR205.6M
Est:EUR228.4M
FY2022MISS
EUR205.6M
FY2023MISS
Actual:EUR245.3M
Est:EUR266.4M
FY2023MISS
EUR245.3M
FY2024BEAT
Actual:EUR297.2M
Est:EUR286.4M
FY2024BEAT
EUR297.2M
FY2025MISS
Actual:EUR333.2M
Est:EUR387.8M
FY2025MISS
EUR333.2M

Analyst Estimates